合并慢性肾脏病的脓毒症患者28天死亡的危险因素分析
Analysis of Risk Factors for 28-Day Death in Sepsis Patients with Chronic Kidney Disease
DOI: 10.12677/acm.2025.1541009, PDF,   
作者: 秦 平:西安医学院研究生工作部,陕西 西安;空军军医大学第二附属医院急诊科,陕西 西安;陈志强, 田小溪*:空军军医大学第二附属医院急诊科,陕西 西安
关键词: 脓毒症慢性肾脏病MIMIC-IV数据库预后Sepsis Chronic Kidney Disease MIMIC-IV Database Prognosis
摘要: 目的:探讨慢性肾脏病合并脓毒症患者的临床特征并分析短期内死亡的危险因素。方法:以MIMIC-IV数据库作为数据来源,选取慢性肾脏病合并脓毒症患者(4288例),收集患者临床资料,根据患者28天预后情况分为存活组(3379例)与死亡组(909例)。应用秩和检验及卡方检验分析死亡组和存活组的临床特征差异,采用Lasso逻辑回归方法及logistic回归分析方法分析慢性肾脏病合并脓毒症患者短期内死亡的独立危险因素。结果:4288例患者中,909例患者在28天内死亡,死亡率为21.20%。存活组与死亡组差异性比较结果显示,两组间的年龄、体重、查尔森合并症指数、SOFA、APSIII、GCS、心率、收缩压、平均动脉压、呼吸频率、体温、血氧饱和度、血糖、红细胞压积、红细胞分布宽度、白细胞计数、阴离子间隙、碳酸氢根、尿素氮、氯离子、肌酐、钾离子、国际标准化比值、凝血酶原时间、活化部分凝血活酶时间、是否使用机械通气及是否使用血管活性药物的差异均有统计学意义(均为P < 0.05)。通过Lasso逻辑回归及logistic回归分析,结果显示,年龄(OR = 1.04, P < 0.001)、体重(OR = 0.99, P < 0.001)、查尔森合并症指数(OR = 1.14, P < 0.001)、APSIII评分(OR = 1.04, P < 0.001)、GCS (OR = 1.05, P = 0.005)、呼吸频率(OR = 1.03, P < 0.001)、SpO2 (OR = 0.98, P = 0.044)、红细胞压积(OR = 1.03, P < 0.001)、RDW (OR = 1.14, P < 0.001)及PTT (OR = 1.01, P = 0.003)是慢性肾脏病合并脓毒症患者短期内死亡的独立危险因素。
Abstract: Objective: To investigate the clinical features of patients with chronic kidney disease and sepsis and to analyze the risk factors for death in the short term. Methods: A total of 4288 patients with chronic kidney disease and sepsis were selected from the MIMIC-IV database, and the clinical data of the patients were collected and divided into survival group (3379 cases) and death group (909 cases) according to the 28-day prognosis. The rank sum test and chi-square test were used to analyze the differences in clinical characteristics between the death group and the survival group, and the Lasso logistic regression method and logistic regression analysis were used to analyze the independent risk factors for short-term death in patients with chronic kidney disease complicated with sepsis. Results: Among the 4288 patients, 909 patients died within 28 days, with a mortality rate of 21.20%. The results of the comparative analysis between the survival group and the death group revealed statistically significant differences in age, body weight, Charlson Comorbidity Index, SOFA score, APSIII score, Glasgow Coma Scale (GCS), heart rate, systolic blood pressure, mean arterial pressure, respiratory rate, body temperature, blood oxygen saturation, blood glucose, hematocrit, red blood cell distribution width, white blood cell count, anion gap, bicarbonate, blood urea nitrogen, chloride, creatinine, potassium, international normalized ratio (INR), prothrombin time, activated partial thromboplastin time, mechanical ventilation use, and vasopressor use (all P < 0.05). The results showed that age (OR = 1.04, P < 0.001), weight (OR = 0.99, P < 0.001), Charleson comorbidity index (OR = 1.14, P < 0.001), APSIII score (OR = 1.04, P < 0.001), GCS (OR = 1.05, P = 0.005), respiratory rate (OR = 1.03, P < 0.001), SpO2 (OR = 0.98, P = 0.044), and hematocrit (OR = 1.03, P < 0.001), RDW (OR = 1.14, P < 0.001) and PTT (OR = 1.01, P = 0.003) were independent risk factors for short-term mortality in patients with chronic kidney disease and sepsis.
文章引用:秦平, 陈志强, 田小溪. 合并慢性肾脏病的脓毒症患者28天死亡的危险因素分析[J]. 临床医学进展, 2025, 15(4): 885-895. https://doi.org/10.12677/acm.2025.1541009

参考文献

[1] Huang, M., Cai, S. and Su, J. (2019) The Pathogenesis of Sepsis and Potential Therapeutic Targets. International Journal of Molecular Sciences, 20, Article 5376. [Google Scholar] [CrossRef] [PubMed]
[2] Ghimire, S., Ravi, S., Budhathoki, R., Arjyal, L., Hamal, S., Bista, A., et al. (2020) Current Understanding and Future Implications of Sepsis‐Induced Thrombocytopenia. European Journal of Haematology, 106, 301-305. [Google Scholar] [CrossRef] [PubMed]
[3] Girndt, M., Sester, M., Sester, U., Kaul, H. and Kohler, H. (2001) Molecular Aspects of T-and B-Cell Function in Uremia. Kidney International, 59, 206-211. [Google Scholar] [CrossRef
[4] McDonald, H.I., Thomas, S.L. and Nitsch, D. (2014) Chronic Kidney Disease as a Risk Factor for Acute Community-Acquired Infections in High-Income Countries: A Systematic Review. BMJ Open, 4, e004100. [Google Scholar] [CrossRef] [PubMed]
[5] Peerapornratana, S., Manrique-Caballero, C.L., Gómez, H. and Kellum, J.A. (2019) Acute Kidney Injury from Sepsis: Current Concepts, Epidemiology, Pathophysiology, Prevention and Treatment. Kidney International, 96, 1083-1099. [Google Scholar] [CrossRef] [PubMed]
[6] Hoste, E.A.J., Kellum, J.A., Selby, N.M., Zarbock, A., Palevsky, P.M., Bagshaw, S.M., et al. (2018) Global Epidemiology and Outcomes of Acute Kidney Injury. Nature Reviews Nephrology, 14, 607-625. [Google Scholar] [CrossRef] [PubMed]
[7] Odutayo, A., Wong, C.X., Farkouh, M., Altman, D.G., Hopewell, S., Emdin, C.A., et al. (2016) AKI and Long-Term Risk for Cardiovascular Events and Mortality. Journal of the American Society of Nephrology, 28, 377-387. [Google Scholar] [CrossRef] [PubMed]
[8] See, E.J., Jayasinghe, K., Glassford, N., Bailey, M., Johnson, D.W., Polkinghorne, K.R., et al. (2019) Long-Term Risk of Adverse Outcomes after Acute Kidney Injury: A Systematic Review and Meta-Analysis of Cohort Studies Using Consensus Definitions of Exposure. Kidney International, 95, 160-172. [Google Scholar] [CrossRef] [PubMed]
[9] Johnson, A.E.W., Bulgarelli, L., Shen, L., Gayles, A., Shammout, A., Horng, S., et al. (2023) Author Correction: MIMIC-IV, a Freely Accessible Electronic Health Record Dataset. Scientific Data, 10, Article No. 31. [Google Scholar] [CrossRef] [PubMed]
[10] Foundation, N.K. (2002) K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification. American Journal of Kidney Diseases, 39, S1-266.
[11] 严丹阳, 基于MIMIC-IV构建及评估脓毒症患者近期和远期死亡风险预测模型[J]. 中南大学学报(医学版), 2024, 49(2): 256-265.
[12] 邢冬梅, 隋冰冰, 王磊. 老年脓毒症患者住院期间死亡风险预测模型的建立与验证[J]. 实用临床医药杂志, 2024, 28(8): 39-44.
[13] Kellum, J.A., Wen, X., de Caestecker, M.P. and Hukriede, N.A. (2019) Sepsis-Associated Acute Kidney Injury: A Problem Deserving of New Solutions. Nephron, 143, 174-178. [Google Scholar] [CrossRef] [PubMed]
[14] Nguyen, A.T., Tsai, C., Hwang, L., Lai, D., Markham, C. and Patel, B. (2016) Obesity and Mortality, Length of Stay and Hospital Cost among Patients with Sepsis: A Nationwide Inpatient Retrospective Cohort Study. PLOS ONE, 11, e0154599. [Google Scholar] [CrossRef] [PubMed]
[15] 王丹妮, 体重指数对脓毒症患者预后的影响: 基于大型临床数据库MIMIC-Ⅲ的回顾性分析[J]. 解放军医学杂志, 2021, 46(2): 129-135.
[16] Porcheray, F., Viaud, S., Rimaniol, A., Léone, C., Samah, B., Dereuddre-Bosquet, N., et al. (2005) Macrophage Activation Switching: An Asset for the Resolution of Inflammation. Clinical and Experimental Immunology, 142, 481-489. [Google Scholar] [CrossRef] [PubMed]
[17] Kershaw, E.E. and Flier, J.S. (2004) Adipose Tissue as an Endocrine Organ. The Journal of Clinical Endocrinology & Metabolism, 89, 2548-2556. [Google Scholar] [CrossRef] [PubMed]
[18] Park, J.Y., Kim, M.H., Bae, E.J., Kim, S., Kim, D.K., Joo, K.W., et al. (2018) Comorbidities Can Predict Mortality of Kidney Transplant Recipients: Comparison with the Charlson Comorbidity Index. Transplantation Proceedings, 50, 1068-1073. [Google Scholar] [CrossRef] [PubMed]
[19] 武登峰, 杜云波, 黄苏平. 查尔森合并症指数、动脉血氨、Toll样受体4水平与严重多发伤合并脓毒症患者病情的关系及其死亡风险预测价值[J]. 临床内科杂志, 2024, 41(6): 393-396.
[20] Pérez-Fernández, X., Sabater-Riera, J., Sileanu, F.E., Vázquez-Reverón, J., Ballús-Noguera, J., Cárdenas-Campos, P., et al. (2017) Clinical Variables Associated with Poor Outcome from Sepsis-Associated Acute Kidney Injury and the Relationship with Timing of Initiation of Renal Replacement Therapy. Journal of Critical Care, 40, 154-160. [Google Scholar] [CrossRef] [PubMed]
[21] Wallgren, U.M., Sjölin, J., Järnbert-Pettersson, H. and Kurland, L. (2020) The Predictive Value of Variables Measurable in the Ambulance and the Development of the Predict Sepsis Screening Tools: A Prospective Cohort Study. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine, 28, Article No. 59. [Google Scholar] [CrossRef] [PubMed]
[22] Boonmee, P., Ruangsomboon, O., Limsuwat, C. and Chakorn, T. (2020) Predictors of Mortality in Elderly and Very Elderly Emergency Patients with Sepsis: A Retrospective Study. Western Journal of Emergency Medicine, 21, 210-218. [Google Scholar] [CrossRef] [PubMed]
[23] Sonneville, R., de Montmollin, E., Poujade, J., Garrouste-Orgeas, M., Souweine, B., Darmon, M., et al. (2017) Potentially Modifiable Factors Contributing to Sepsis-Associated Encephalopathy. Intensive Care Medicine, 43, 1075-1084. [Google Scholar] [CrossRef] [PubMed]
[24] 吴华初. 急性肾损伤患者早期预后预测模型的建立与外部验证[D]: [硕士学位论文]. 广州: 广州医科大学,2024.
[25] 黄樱菲, 陈矛, 姜悦, 严重脓毒症及脓毒性休克患者SV、ScVO2、乳酸清除率、心肌酶学的相关性研究[J]. 海南医学, 2016, 4(27): 551-553.
[26] 李国吾, 武玉荣. 中心静脉血氧饱和度及乳酸清除率达目标水平在脓毒症休克患者预后中的价值比较[J]. 中国临床研究, 2015, 28(2): 179-180.
[27] 罗运山, 刘易林, 李莉. 动态监测血LAC、CRP及ScvO2水平对评估脓毒症预后的价值研究[J]. 人民军医, 2016, 59(12): 1239-1241.
[28] 吕慧. 红细胞压积和抗凝血酶Ⅲ联合APACHE Ⅱ评分在老年脓毒症患者90天预后中的评估价值[J]. 老年医学与保健, 2022, 28(6): 1181-1186.
[29] Zhang, L., Yu, C., Guo, K., Huang, C. and Mo, L. (2020) Prognostic Role of Red Blood Cell Distribution Width in Patients with Sepsis: A Systematic Review and Meta-analysis. BMC Immunology, 21, Article No. 40. [Google Scholar] [CrossRef] [PubMed]
[30] Angus, D.C. and van der Poll, T. (2013) Severe Sepsis and Septic Shock. New England Journal of Medicine, 369, 840-851. [Google Scholar] [CrossRef] [PubMed]
[31] 周醒, 谢剑锋, 杨毅. 脓毒症相关凝血功能障碍的机制及药物治疗进展[J]. 中华内科杂志, 2022, 61(2): 224-228.
[32] 侯宇, 敖雪, 苏醒. 不同病情严重程度脓毒症患者凝血功能的变化及对预后的影响[J]. 中国现代医学杂志, 2023, 33(22): 70-75.